English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Emotional Processing And Brain Metabolism After Pharmacological Stimulation With Ketamine: Implications For Major Depression

Scheidegger, M., Henning, A., Fuchs, A., Krähenmann, R., Böker, H., Bösiger, P., et al. (2011). Emotional Processing And Brain Metabolism After Pharmacological Stimulation With Ketamine: Implications For Major Depression. Poster presented at 66th Society of Biological Psychiatry Annual Meeting 2011, San Francisco, CA, USA.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-0013-BBF6-2 Version Permalink: http://hdl.handle.net/21.11116/0000-0002-4FB2-D
Genre: Poster

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Scheidegger, M, Author
Henning, A1, Author              
Fuchs, A, Author
Krähenmann, R, Author
Böker, H, Author
Bösiger, P, Author
Seifritz, E, Author
Walter, M, Author              
Grimm, S, Author
Affiliations:
1ETH and University Zürich, ou_persistent22              

Content

show
hide
Free keywords: -
 Abstract: Background / Purpose: Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at subanaesthetic doses, thus providing a valuable research tool for the investigation of the neurobiology of major depressive disorder (MDD). This multimodal imaging study in 23 healthy subjects reveals the neuropharmacological effects of a single intravenous subanaesthetic ketamine infusion on fMRI-BOLD responses during an emotional processing task and their relationship to glutamatergic metabolite concentrations in the pregenual anterior cingulate cortex (PACC) assessed by proton magnetic resonance spectroscopy (1H-MRS). Main conclusion: Our findings show that ketamine has the potential to increase negative BOLD responses (NBRs) in PACC, which have been found to be decreased in MDD patients during an emotional processing task. A correlation between glutamate/glutamine ratios as a putative spectroscopic marker of glutamatergic neurotransmission and task associated NBRs could be found after ketamine administration compared to baseline. Our multimodal findings suggest that the increased NBRs observed during ketamine infusion are most likely interpreted in terms of an increased baseline brain metabolism due to an increase in the glutamate-glutamine-cycling rate. Hence, the antidepressant effect of ketamine might be linked to a beneficial short-term influence on glutamatergic neurotransmission and cerebral neuroenergetics. Next steps: The same research protocol will be applied for MDD patients.

Details

show
hide
Language(s):
 Dates: 2011-05
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: BibTex Citekey: ScheideggerHFKBBSWG2011
DOI: 10.1016/j.biopsych.2011.03.031
 Degree: -

Event

show
hide
Title: 66th Society of Biological Psychiatry Annual Meeting 2011
Place of Event: San Francisco, CA, USA
Start-/End Date: 2011-05-12 - 2011-05-14

Legal Case

show

Project information

show

Source 1

show
hide
Title: Biological Psychiatry
  Other : Biol. Psychiatry
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: New York : Elsevier
Pages: - Volume / Issue: 69 (9 Supplement) Sequence Number: 580 Start / End Page: 175 Identifier: ISSN: 0006-3223
CoNE: https://pure.mpg.de/cone/journals/resource/954925384111